Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Yifeng Pharmacy Chain (603939.SS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Rmb) Price Target (Rmb) Rating
2022-03-3023.9251.19Buy
2022-05-1825.2935.714Buy
2022-08-3031.3238.988Buy
2023-04-1134.0144.643Buy
2023-05-0531.1841.075Buy
2023-08-2930.5140.417Buy
2023-10-3127.3037.50Buy
2024-04-3036.6241.25Buy
2024-10-0827.5634.00Buy
2024-11-0126.1038.00Buy
2025-04-2928.0040.00Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.